Clinical Trial Update: L-Glutamine Therapy for Sickle Cell Anemia and Sickle ß0 Thalassemia [Phase 2]

View source ↗

Summary

Phase 2 clinical trial of L-Glutamine therapy for sickle cell anemia and sickle beta-zero thalassemia completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Sickle Cell Disease
• Thalassemia

Drugs mentioned

• L-GLUTAMINE (L-Glutamine)

Snippet

Sponsor: Emmaus Medical, Inc. | Conditions: Sickle Cell Anemia, Thalassemia | Phase 2 | Status: COMPLETED | Results posted: 2021-01-29